Create Account
Log In
Dark
chart
exchange
Premium
Terminal
Screener
Stocks
Crypto
Forex
Trends
Depth
Close
Check out our API


Immutep Reports Its Phase 2 Study For Ulcerative Colitis, GSK2831781, Discontinued


Benzinga | Jan 21, 2021 05:05PM EST

Immutep Reports Its Phase 2 Study For Ulcerative Colitis, GSK2831781, Discontinued

-Reuters






Share
About
Pricing
Policies
Markets
API
Info
tz UTC-4
Connect with us
ChartExchange Email
ChartExchange on Discord
ChartExchange on X
ChartExchange on Reddit
ChartExchange on GitHub
ChartExchange on YouTube
© 2020 - 2026 ChartExchange LLC